You are here

MYOFINITY BIOSCIENCES INC

Company Information
Address
4 RESEARCH DR
WOODBRIDGE, CT 06525-2347
United States



Information

UEI: JF5CJQH8NNH1

# of Employees: 1


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. Translational development of novel CRISPR approach to treat genomic duplications

    Amount: $275,651.00

    PROJECT ABSTRACT The goal of this Phase I STTR project is to accomplish key milestones in commercializing a novel SaCas9 nickase-based system (CRD-002) to treat dystrophinopathies in order to restore ...

    STTRPhase I2023Department of Health and Human Services National Institutes of Health
  2. Membrane repair as a therapeutic intervention for treating Becker Muscular Dystrophy

    Amount: $295,536.00

    PROJECT ABSTRACTThe goal of this combined Phase I/II SBIR project is to accomplish key milestones in commercializing a protein therapeutic for Becker muscular dystrophy (BMD) that will enhance the rep ...

    STTRPhase I2023Department of Health and Human Services National Institutes of Health
  3. Translational development of recombinant protein therapeutic for LGMD2B

    Amount: $259,487.00

    PROJECT ABSTRACTThis Phase I STTR project will accomplish key milestones in commercializing a protein therapeutic for dysferlinopathies that will enhance the repair capacity of muscle cell membranes c ...

    STTRPhase I2022Department of Health and Human Services National Institutes of Health
  4. Optimizing membrane repair for the treatment of Duchenne muscular dystrophy

    Amount: $224,811.00

    PROJECT ABSTRACT The long term goal of this project is to optimize a protein therapeutic for Duchenne muscular dystrophyDMDand potentially other muscle diseasesthat will enhance the repair capacity of ...

    STTRPhase I2019Department of Health and Human Services National Institutes of Health
  5. Genome-wide CRISPR screen to identify pro-myogenic factors for cell therapy of DMD

    Amount: $224,725.00

    Project Abstract Myos Incis developing a cell therapy treatment for patients with Duchenne muscular dystrophyDMDbased on HLA matched donor cells that are pretreated with small molecule cocktails ex vi ...

    STTRPhase I2018Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government